• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名17岁台湾女性新发精神病患者可能由缓释帕利哌酮诱发血清素综合征的病例报告。

A Case Report of Probable Paliperidone ER-Induced Serotonin Syndrome in a 17-Year-Old Taiwanese Female With New Onset Psychosis.

作者信息

Yang Chung-Hao, Juang Kai-Dih, Chou Po-Han, Chan Chin-Hong

机构信息

From the Department of Psychiatry (C-HY, K-DJ, P-HC), Taichung Veterans Hospital, Taichung; and Department of Psychiatry (C-HC), Conde S. Januário General Hospital, Macau, China.

出版信息

Medicine (Baltimore). 2016 Mar;95(9):e2930. doi: 10.1097/MD.0000000000002930.

DOI:10.1097/MD.0000000000002930
PMID:26945397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4782881/
Abstract

A 17-year-old female with new-onset psychosis was treated with paliperidone. After increasing the paliperidone dose to 12 mg per day the patient developed a series of side effects; Tachycardia (140 bpm), severe drooling, restlessness, diaphoresis, whole-body tremor, inducible foot clonus, predominant lower limbs rigidity, bilateral pupil dilation, increased bowel sounds with watery diarrhea, and muscle hypertonicity. The symptoms subsided after stopping the paliperidone, and recurred after resuming paliperidone 9 mg per day. To our knowledge, this is the first case of a very clear and close relationship between the symptoms of serotonin syndrome and the use of paliperidone. We have to cautiously consider the diagnosis of serotonin syndrome in potential cases.

摘要

一名17岁新发精神病女性患者接受了帕利哌酮治疗。在将帕利哌酮剂量增加至每日12毫克后,患者出现了一系列副作用;心动过速(140次/分)、严重流涎、烦躁不安、多汗、全身震颤、可诱导的足阵挛、以下肢为主的强直、双侧瞳孔散大、肠鸣音亢进伴水样腹泻以及肌肉张力亢进。停用帕利哌酮后症状缓解,在恢复每日9毫克帕利哌酮治疗后症状复发。据我们所知,这是第一例血清素综合征症状与帕利哌酮使用之间存在非常明确且密切关系的病例。对于潜在病例,我们必须谨慎考虑血清素综合征的诊断。

相似文献

1
A Case Report of Probable Paliperidone ER-Induced Serotonin Syndrome in a 17-Year-Old Taiwanese Female With New Onset Psychosis.一名17岁台湾女性新发精神病患者可能由缓释帕利哌酮诱发血清素综合征的病例报告。
Medicine (Baltimore). 2016 Mar;95(9):e2930. doi: 10.1097/MD.0000000000002930.
2
Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study.帕利哌酮长效注射剂治疗青少年精神分裂症的疗效和安全性:一项随机、双盲研究。
J Am Acad Child Adolesc Psychiatry. 2015 Feb;54(2):126-137.e1. doi: 10.1016/j.jaac.2014.11.009. Epub 2014 Nov 25.
3
Lithium carbonate as a treatment for paliperidone extended-release-induced leukopenia and neutropenia in a patient with schizoaffective disorder; a case report.碳酸锂治疗精神分裂症伴情感障碍患者因使用帕利哌酮缓释片引起的白细胞减少和中性粒细胞减少:一例报告
BMC Psychiatry. 2016 May 26;16:161. doi: 10.1186/s12888-016-0874-x.
4
Olanzapine as a possible replacement choice for paliperidone-induced Pisa syndrome: a case report.奥氮平作为帕利哌酮所致 Pisa 综合征的一种可能替代选择:一例病例报告。
Australas Psychiatry. 2016 Dec;24(6):545-547. doi: 10.1177/1039856216665285. Epub 2016 Sep 2.
5
Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?帕利哌酮延长心脏心室复极:如何以及有多少?
J Cardiovasc Pharmacol. 2011 Jun;57(6):690-5. doi: 10.1097/FJC.0b013e318217d941.
6
Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study.为期 2 年的帕利哌酮长效释放剂治疗精神分裂症青少年中潜在与催乳素相关的不良反应和性成熟的评估:一项开放标签多中心研究的事后分析。
CNS Drugs. 2017 Sep;31(9):797-808. doi: 10.1007/s40263-017-0437-9.
7
Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks.每3周给药一次的棕榈酸帕利哌酮的血清浓度
Psychopharmacol Bull. 2019 Jun 20;49(2):57-62.
8
Long-Term Safety of Paliperidone Extended Release in Adolescents with Schizophrenia: An Open-Label, Flexible Dose Study.帕利哌酮缓释片治疗青少年精神分裂症的长期安全性:一项开放标签、灵活剂量研究
J Child Adolesc Psychopharmacol. 2015 Sep;25(7):548-57. doi: 10.1089/cap.2014.0130. Epub 2015 Jul 28.
9
Delirium with anticholinergic symptoms after a combination of paliperidone and olanzapine pamoate in a patient known to smoke cannabis: an unfortunate coincidence.一名已知吸食大麻的患者在联用帕利哌酮和奥氮平棕榈酸酯后出现伴有抗胆碱能症状的谵妄:一次不幸的巧合。
BMJ Case Rep. 2016 Jun 22;2016:bcr2016214806. doi: 10.1136/bcr-2016-214806.
10
The possibility of the treatment for long-acting injectable antipsychotics induced severe side effects.
Am J Emerg Med. 2017 Aug;35(8):1211.e1-1211.e2. doi: 10.1016/j.ajem.2017.04.063. Epub 2017 Apr 27.

本文引用的文献

1
Possible paliperidone-induced neuroleptic malignant syndrome: a case report.帕利哌酮可能诱发的抗精神病药恶性综合征:一例报告
J Neuropsychiatry Clin Neurosci. 2012 Summer;24(3):E22-3. doi: 10.1176/appi.neuropsych.11070156.
2
Paliperidone-induced neuroleptic malignant syndrome.帕利哌酮诱发的抗精神病药恶性综合征。
J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):E14-5. doi: 10.1176/jnp.23.1.jnpe14.
3
Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.帕利哌酮相关的非典型抗精神病药恶性综合征:一例报告
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):650-1. doi: 10.1016/j.pnpbp.2010.12.006. Epub 2010 Dec 14.
4
Possible neuroleptic malignant syndrome during paliperidone administration: a case report.帕利哌酮给药期间可能出现的神经阻滞剂恶性综合征:一例报告。
J Clin Psychopharmacol. 2010 Feb;30(1):89-91. doi: 10.1097/JCP.0b013e3181c9c7ef.
5
Possible neuroleptic malignant syndrome associated with paliperidone.与帕利哌酮相关的可能的抗精神病药恶性综合征。
J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):477-8. doi: 10.1176/jnp.2007.19.4.477.
6
5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression.5-羟色胺7、神经发生与抗抑郁药:一条治疗抑郁症的前景广阔的治疗途径
Clin Exp Pharmacol Physiol. 2007 May-Jun;34(5-6):546-51. doi: 10.1111/j.1440-1681.2007.04608.x.
7
The serotonin syndrome.血清素综合征
N Engl J Med. 2005 Mar 17;352(11):1112-20. doi: 10.1056/NEJMra041867.
8
Serotonin syndrome: a brief review.血清素综合征:简要综述。
CMAJ. 2003 May 27;168(11):1439-42.
9
Serotonin syndrome. A clinical update.血清素综合征。临床最新进展。
Crit Care Clin. 1997 Oct;13(4):763-83. doi: 10.1016/s0749-0704(05)70368-7.
10
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.